270 related articles for article (PubMed ID: 35276064)
1. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM
Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064
[TBL] [Abstract][Full Text] [Related]
2. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
4. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Zongo I; Dorsey G; Rouamba N; Tinto H; Dokomajilar C; Guiguemde RT; Rosenthal PJ; Ouedraogo JB
Lancet; 2007 Feb; 369(9560):491-8. PubMed ID: 17292769
[TBL] [Abstract][Full Text] [Related]
5. AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.
Koita OA; Sangaré L; Miller HD; Sissako A; Coulibaly M; Thompson TA; Fongoro S; Diarra Y; Ba M; Maiga A; Diallo B; Mushatt DM; Mather FJ; Shaffer JG; Anwar AH; Krogstad DJ
Lancet Infect Dis; 2017 Dec; 17(12):1266-1275. PubMed ID: 28916443
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Tripura R; von Seidlein L; Sovannaroth S; Peto TJ; Callery JJ; Sokha M; Ean M; Heng C; Conradis-Jansen F; Madmanee W; Peerawaranun P; Waithira N; Khonputsa P; Jongdeepaisal M; Pongsoipetch K; Chotthanawathit P; Soviet U; Pell C; Duanguppama J; Rekol H; Tarning J; Imwong M; Mukaka M; White NJ; Dondorp AM; Maude RJ
Lancet Infect Dis; 2023 Jan; 23(1):81-90. PubMed ID: 36174595
[TBL] [Abstract][Full Text] [Related]
7. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
[TBL] [Abstract][Full Text] [Related]
8. Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Ogutu B; Yeka A; Kusemererwa S; Thompson R; Tinto H; Toure AO; Uthaisin C; Verma A; Kibuuka A; Lingani M; Lourenço C; Mombo-Ngoma G; Nduba V; N'Guessan TL; Nassa GJW; Nyantaro M; Tina LO; Singh PK; El Gaaloul M; Marrast AC; Chikoto H; Csermak K; Demin I; Mehta D; Pathan R; Risterucci C; Su G; Winnips C; Kaguthi G; Fofana B; Grobusch MP
Lancet Infect Dis; 2023 Sep; 23(9):1051-1061. PubMed ID: 37327809
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
[TBL] [Abstract][Full Text] [Related]
10. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Pryce J; Hine P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
[TBL] [Abstract][Full Text] [Related]
11. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
14. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique.
Nhama A; Bassat Q; Enosse S; Nhacolo A; Mutemba R; Carvalho E; Naueia E; Sevene E; Guinovart C; Warsame M; Sanz S; Mussa A; Matsinhe G; Alonso P; Tiago A; Macete E
Malar J; 2014 Aug; 13():309. PubMed ID: 25108397
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP
Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069
[TBL] [Abstract][Full Text] [Related]
19. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
Meremikwu M; Alaribe A; Ejemot R; Oyo-Ita A; Ekenjoku J; Nwachukwu C; Ordu D; Ezedinachi E
Malar J; 2006 May; 5():43. PubMed ID: 16704735
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
